Clinical Trial Update: Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy data for Ingenol Mebutate applied once daily for 2 or 3 consecutive days in subjects with actinic keratos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-25